Skip to main content

Astellas Pharma Inc(ALPMY)
OTC US

Today's Change
Delayed Last Update
Volume

Astellas Pharma Inc

2-5-1 Nihonbashi-Honcho Chuo-Ku
Tokyo M0 103-8411 JPN
P: 813-3244-3000
http://www.astellas.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.

    Key Executives

    NameTitle
    Information not available.